Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody-Reference-Cited by-同舟云学术

Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody

Published:2016-10-03 Issue:5 Volume:8 Page:8807-8817
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Nagaya Tadanobu¹,Nakamura Yuko¹,Sato Kazuhide¹,Harada Toshiko¹,Choyke Peter L.¹,Hodge James W.²,Schlom Jeffrey²,Kobayashi Hisataka¹

Affiliation:

1. Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America

2. Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Near‐infrared photoimmunotherapy targeting PD‐L1: Improved efficacy by preconditioning the tumor microenvironment;Cancer Science;2024-04-26

2. PD‐L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self‐Delivery;Advanced Healthcare Materials;2024-03-14

3. ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors;EJNMMI Research;2024-01-05

4. Activatable near-infrared fluorescence probe for real-time imaging of PD-L1 expression in tumors;Journal of Materials Chemistry B;2024

5. Photodynamic therapy combined with immunotherapy: Recent advances and future research directions;Coordination Chemistry Reviews;2023-11